Mark Daniel Pegram
American Society of Clinical Oncology
2 papers in the Anchorcite directory, published between 2001 and 2006, cited 16,102 times in total.
ORCID profileResearch topics
- HER2/EGFR in Cancer Research · 2 papers
- Gastric Cancer Management and Outcomes · 2 papers
- Cancer Treatment and Pharmacology · 1 paper
- Breast Cancer Treatment Studies · 1 paper
Frequent co-authors
- Dennis J. Slamon · 1 paper
- Brian R Leyland-Jones · 1 paper
- Steven Shak · 1 paper
- H. Fuchs · 1 paper
- Virginia E. Paton · 1 paper
- Alex Bajamonde · 1 paper
- Wolfgang EIERMANN · 1 paper
- Janet M. Wolter · 1 paper
Papers
- Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2New England Journal of Medicine · 2001 · 11,674 citations
BACKGROUND: The HER2 gene, which encodes the growth factor receptor HER2, is amplified and HER2 is overexpressed in 25 to 30 percent of breast cancers, increasing the aggressiveness of the tumor. METHODS: We evaluated the efficacy and safety of trastuzumab,…
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast CancerJournal of Clinical Oncology · 2006 · 4,428 citations
PURPOSE: To develop a guideline to improve the accuracy of human epidermal growth factor receptor 2 (HER2) testing in invasive breast cancer and its utility as a predictive marker. METHODS: The American Society of Clinical Oncology and the College of…
Metadata from OpenAlex (CC0).